skip to main content

COVID-19 Information and Guidance

Research Library

Center for Health and Biosciences

Biomedical Research

Unproven stem cell-based interventions and harm to existing and future patients

Kirstin R.W. Matthews | Flora Naylor

Unproven stem cell-based interventions and harm to existing and future patients.

Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).